Annual Report

Overview

The report describes a sharp decline in operating revenue following national insulin volume-based procurement, while the company continued substantial research and development investment. It also highlights photovoltaic power generation and other carbon-reduction measures during 2022. Social responsibility activities included major education donations and community diabetes-awareness initiatives.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Publication date: 29 March 2023
Language: English, Chinese
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services